FORCE is hosting two informative webinars in October for people affected by hereditary breast and ovarian cancer.
FORCE is hosting two informative webinars in October for people affected by hereditary breast and ovarian cancer. These online seminars feature presentations by experts on topics of importance to healthcare providers, patients, survivors, and “previvors.” Participants also can submit questions to the speakers to answer at the end of each webinar.
BRCA and Men: Medical Management and Prostate-Specific Considerations
Wednesday, October 1 — 12:00-1:30 pm EST
BRCA mutations increase cancer risk for men too. How can men to manage their cancer risk? Join Certified Genetic Counselor Jacquelyn Powers of the Basser Research Center for BRCA at the University of Pennsylvania Abramson Cancer Center for a discussion of cancer risks for men with BRCA mutations and the medical management options available.
To register for this webinar, click here.
Screening and Nonsurgical Methods of Prevention for Women at High Risk for Breast Cancer
Wednesday, October 22 — 12:00-1:30 pm EST
Join medical oncologist Victoria Seewaldt, MD of the Duke Comprehensive Cancer Center as she discusses early detection of breast cancer as well as nonsurgical options for breast cancer prevention in high-risk women.
To register for this webinar, click here.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.